AI-Integrated Implantable Intraluminal Devices

This invention integrates AI, IoT, blockchain, and nanomaterials with implantable intraluminal devices to enhance fluid flow monitoring, optimize device performance, and improve patient outcomes.

The original patent described implantable intraluminal devices, but these devices lacked real-time monitoring capabilities, data security, and advanced materials. The new inventive concept addresses these limitations by integrating distinct technologies to create a more powerful system.

The AI-integrated implantable intraluminal device system comprises a primary device with a first, elongate tubular member and an AI-powered sensor for monitoring fluid flow and detecting potential blockages. The system can be integrated with an IoT-enabled communication system for real-time flow data transmission to a remote monitoring station. Additionally, a blockchain-secured data storage system can be used to record and verify device performance data. The device can also feature a nanomaterial-enhanced membrane for improved biocompatibility and fluid flow. The system can be further enhanced with machine learning-based algorithms for predicting potential device failures and alerting medical professionals.

The new claims introduce the integration of AI, IoT, blockchain, and nanomaterials with implantable intraluminal devices, which is not obvious from the original patent. The inventive step lies in combining these distinct technologies to create a more powerful system that enhances fluid flow monitoring, optimizes device performance, and improves patient outcomes.

Alternative embodiments could include integrating the device with other advanced technologies, such as augmented reality or 5G networks. Variations could include different nanomaterials or AI algorithms tailored to specific medical conditions or patient populations.

The AI-integrated implantable intraluminal device system has significant commercial potential in the medical device industry, particularly in the fields of cardiovascular and neurovascular medicine. The system's advanced features and improved patient outcomes could lead to increased market share and revenue growth.